Last reviewed · How we verify
PEG/electrolytes 2L/2L split dose — Competitive Intelligence Brief
marketed
Osmotic laxative
Gastroenterology
Small molecule
Live · refreshed every 30 min
Target snapshot
PEG/electrolytes 2L/2L split dose (PEG/electrolytes 2L/2L split dose) — McGill University Health Centre/Research Institute of the McGill University Health Centre. PEG/electrolytes solution acts as an osmotic laxative that draws water into the bowel lumen to promote bowel evacuation.
Comparator set (6 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| PEG/electrolytes 2L/2L split dose TARGET | PEG/electrolytes 2L/2L split dose | McGill University Health Centre/Research Institute of the McGill University Health Centre | marketed | Osmotic laxative | ||
| Pizensy | LACTITOL | Braintree Labs | marketed | Osmotic Laxative | 2020-01-01 | |
| Miralax | Macrogol | Braintree | marketed | Osmotic Laxative [EPC] | 1984-01-01 | |
| Cephulac | LACTULOSE | Sanwa Kagaku Kenkyusho Co., Ltd. | marketed | Osmotic Laxative [EPC] | 1976-01-01 | |
| Milk of Magnesia | magnesium hydroxide | Generic (multiple manufacturers) | marketed | Osmotic laxative, Antacid | Gastric acid (direct neutralization) + osmotic effect in intestine | 1880-01-01 |
| PEG-Lyte® | PEG-Lyte® | The Hospital for Sick Children | marketed | Osmotic laxative | ||
| Polyethylene glycol electrolyte | Polyethylene glycol electrolyte | Ningbo No. 1 Hospital | marketed | Osmotic laxative |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
- — Miralax · 10780112 · US
- — Miralax · 11529368 · US
- — Miralax · 10792306 · US
- — Miralax · 10646512 · US
- — Miralax · 9592252 · US
- — Miralax · 9326969 · US
- — Miralax · 9707297 · US
- — Miralax · 8999313 · US
- — Miralax · 10918723 · US
- — Miralax · 10016504 · US
Sponsor landscape (Osmotic laxative class)
- Brooke Army Medical Center · 2 drugs in this class
- Cleveland Clinic Florida · 2 drugs in this class
- Gastroenterology Services, Ltd. · 2 drugs in this class
- Ipsen · 2 drugs in this class
- Benaroya Research Institute · 1 drug in this class
- Bo-In Lee · 1 drug in this class
- Amsterdam UMC, location VUmc · 1 drug in this class
- C.B. Fleet Company, Inc. · 1 drug in this class
- Bayer · 1 drug in this class
- Braintree Laboratories · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- PEG/electrolytes 2L/2L split dose CI watch — RSS
- PEG/electrolytes 2L/2L split dose CI watch — Atom
- PEG/electrolytes 2L/2L split dose CI watch — JSON
- PEG/electrolytes 2L/2L split dose alone — RSS
- Whole Osmotic laxative class — RSS
Cite this brief
Drug Landscape (2026). PEG/electrolytes 2L/2L split dose — Competitive Intelligence Brief. https://druglandscape.com/ci/peg-electrolytes-2l-2l-split-dose. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab